An esophageal motor disorder characterized by a loss of esophageal peristalsis and failure of the lower esophageal sphincter to relax in response to swallowing.
The most common presenting symptoms are dysphagia to solids and liquids, regurgitation, and retrosternal pain. These can be slowly progressive over months or years.
The first investigation for any patient with dysphagia is usually endoscopy to exclude malignancy. Subsequent barium swallow studies and esophageal manometry are often required to establish the diagnosis of achalasia.
Treatment is symptomatic, not curative, and is primarily aimed at relieving dysphagia; options include pharmacologic, endoscopic, and surgical procedures.
Achalasia is an esophageal motor disorder of unknown etiology, characterized by esophageal aperistalsis and insufficient lower esophageal sphincter relaxation in response to swallowing. This results from loss of inhibitory nitrinergic neurons in the esophageal myenteric plexus.
History and exam
Jin-Yong Kang, MD, PhD, FRCP, FRCPEd, FRACP
Honorary Consultant Gastroenterologist
St George's Hospital
JYK declares that he has no competing interests.
Kalliopi Alexandropoulou, MD, FRCP
Royal Surrey County Hospital
KA declares that he has no competing interests.
Dr Jin-Yong Kang would like to gratefully acknowledge Kalliopi Alexandropoulou, a previous contributor to this topic. KA declares that she has no competing interests.
Nigel Trudgill, MB ChB
Sandwell General Hospital
NT declares that he has no competing interests.
John de Caestecker, BChir
Consultant in General Medicine
Leicester General Hospital
JdC declares that he has no competing interests.
David Hackam, MD, PhD
Assistant Professor of Surgery
Children's Hospital of Pittsburgh
DH declares that he has no competing interests.
George Y. Wu, MD, PhD
Professor of Medicine
University of Connecticut Health Center
GYW is on the medical advisory boards of the following: Gilead Sciences, Bristol-Myers Squibb, AbbVie, and Intercept.
Use of this content is subject to our disclaimer